Dechra Pharmaceuticals (DPH) Share Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dechra Pharmaceuticals in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" DPH shares.
View DPH analyst ratings or view top-rated stocks.

5 Wall Street research analysts have issued 1-year price objectives for Dechra Pharmaceuticals' shares. Their DPH share price forecasts range from GBX 2,850 to GBX 4,070. On average, they predict the company's share price to reach GBX 3,606.40 in the next year. This suggests that the stock has a possible downside of 4.8%.
View analysts price targets for DPH or view top-rated stocks among Wall Street analysts.

Dechra Pharmaceuticals' stock was trading at GBX 2,618 on January 1st, 2023. Since then, DPH stock has increased by 44.7% and is now trading at GBX 3,788.
View the best growth stocks for 2023 here.

Dechra Pharmaceuticals announced a dividend on Monday, February 27th. Shareholders of record on Thursday, March 9th will be paid a dividend of GBX 12.50 per share on Thursday, April 13th. This represents a dividend yield of 0.4%. The ex-dividend date is Thursday, March 9th. The official announcement can be accessed at this link.
Read our dividend analysis for DPH.

Dechra Pharmaceuticals (LON:DPH) pays an annual dividend of GBX 45 per share and currently has a dividend yield of 1.19%. The dividend payout ratio is 12,500.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for DPH.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dechra Pharmaceuticals investors own include 32Red (TTR), 1428686 (SGP.L) (SGP), JD Sports Fashion (JD), Ashtead Group (AHT), Cranswick (CWK), Drax Group (DRX), RPC Group (RPC), Robert Walters (RWA), SEB (SKP) and Barratt Developments (BDEV).

Dechra Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "DPH."

Shares of DPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of DPH stock can currently be purchased for approximately GBX 3,788.

Dechra Pharmaceuticals (LON:DPH) has a market capitalization of £4.31 billion and generates £726.80 million in revenue each year. The company earns £40.10 million in net income (profit) each year or GBX 0.36 on an earnings per share basis.

The company employs 1,998 workers across the globe.

Dechra Pharmaceuticals' mailing address is 24 Cheshire Business Park Cheshire Avenue, NORTHWICH, CW9 7UA, United Kingdom. The official website for the company is www.dechra.com. The company can be reached via phone at +44-1606-814730.